A Multi-Measure, Longitudinal Pain Case Study

Pain clinical trial endpoints often rely on episodic, clinic-based assessments and single pain scores. But subjective pain ratings are highly variable, influenced by mood, sleep, baseline function, and expectations, which contributes to high placebo response and forces sponsors to compensate with larger, costlier trials.

This case study explores how a repeat, multi-measure, at-home measurement strategy more clearly characterized pain resolution and functional recovery following total hip replacement, using surgery as a constrained, real-world model of pain recovery.

Why Pain Clinical Trial Endpoints Miss Recovery

Between clinic visits, meaningful fluctuations in pain, function, and activity go unobserved, so recovery milestones are inferred rather than directly measured. And when improvement is expected, as it is after surgery, the harder questions are when meaningful recovery occurs and whether reductions in pain actually align with real-world functional improvement. Episodic assessment alone cannot answer either.

A Multi-Measure, At-Home Strategy

Koneksa followed 24 participants from baseline through six weeks post-surgery using seven clinical outcome assessments spanning patient-reported, clinician-reported, and performance-based measures, paired with continuous wearable capture of mobility, physiology, and sleep. In-clinic visits were limited to baseline and end of participation. Longitudinal analysis revealed coordinated recovery patterns across domains, including a distinct recovery inflection point that episodic assessment would have missed entirely.

Download the Full Case Study

Complete the form to access the full resource.

What You'll Learn

How integrating patient-reported, clinician-reported, performance-based, and device-derived measures improved interpretability
How longitudinal analysis identified meaningful recovery trajectories, and when the recovery inflection point occurred
Implications for designing clearer, more sensitive pain clinical trial endpoints
Why single pain endpoints may fail to reflect coordinated recovery across domains
How multi-measure integration strengthened signal detection without increasing sample size

Related Resources

Cardiovascular measurement overview showing Koneksa's framework across cardiac physiology, mobility, imaging, biomarkers, and PROs
Cardiovascular MeasurementFact Sheet

Cardiovascular Measurement

Pain clinical trial endpoints case study cover showing multi-measure pain recovery study from Koneksa
Revealing the Path of Pain RecoveryCase Study

Revealing the Path of Pain Recovery

Pain measurement evidence snapshot comparing under 1% pain drug approval rate to 6.5% for novel drugs
Evidence Snapshot: PainFact Sheet

Evidence Snapshot: Pain